Skip to main navigation
Close

Here for you, every second

Locations

  • United Kingdom 
    Kiniksa Pharmaceuticals
    International, plc
    Kiniksa Pharmaceuticals (UK), Ltd.
    Second Floor
    105 Piccadilly
    London, UK
    W1J 7NJ
  • USA Headquarters
    Kiniksa Pharmaceuticals Corp.
    100 Hayden Avenue
    Lexington, MA 02421 USA
    (781) 431-9100
  • Switzerland
    Kiniksa Pharmaceuticals, GmbH
    Grafenaustrasse 5
    6300 Zug, Switzerland
  • USA California
    Kiniksa Pharmaceuticals Corp.
    3366 N. Torrey Pines Court
    #320
    La Jolla, CA 92037

Utility

  • Contact Us
Home

Main navigation

  • About Us
    • Leadership
    • Partnerships
    • Compliance & Ethics
    • Grants & Giving
  • Medicines & Pipeline
    • Medicine
    • Pipeline
    • Disease Registries
    • Treatment Access
  • Patients & Advocacy
    • Our Disease Areas
    • Patient Advocacy
    • Stay Informed
  • Investors
  • For Healthcare Professionals
    • Congress Materials
    • Manuscript Publications
    • Medical Information Resources
  • Join Us
Menu

IR navigation

  • News & Events
    • Press Releases
    • Events and Presentations
    • Articles
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
  • Financial Information
    • SEC Filings
    • Annual Reports & Proxy Statement
    • Tax Information
  • Corporate Governance
    • Documents & Charters
    • Board of Directors
    • Management
    • Committee Composition
  • Investor Resources
    • Investor FAQs
    • Investor Contacts
    • Email Alerts

Press Releases

  • All
  • 2026
  • 2025
  • 2024
  • 10/31/23

    Kiniksa Pharmaceuticals Reports Third Quarter 2023 Financial Results and Recent Portfolio Execution

  • 10/24/23

    Kiniksa Pharmaceuticals to Report Third Quarter 2023 Financial Results on October 31, 2023

  • 07/25/23

    Kiniksa Pharmaceuticals Reports Second Quarter 2023 Financial Results and Recent Portfolio Execution

  • 07/17/23

    Kiniksa Pharmaceuticals to Report Second Quarter 2023 Financial Results on July 25, 2023

  • 06/06/23

    Kiniksa Pharmaceuticals to Present at Goldman Sachs 44th Annual Global Healthcare Conference

  • 05/02/23

    Kiniksa Pharmaceuticals Reports First Quarter 2023 Financial Results and Recent Portfolio Execution

  • 05/01/23

    Kiniksa Pharmaceuticals to Report First Quarter 2023 Financial Results on May 2, 2023

  • 02/28/23

    Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Portfolio Execution

  • 02/27/23

    Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2022 Financial Results on February 28, 2023

  • 01/09/23

    Kiniksa Pharmaceuticals Provides Corporate and Portfolio Update

  • 01/03/23

    Kiniksa Pharmaceuticals to Present at 41st Annual J.P. Morgan Healthcare Conference

Print Page
RSS
Email Alerts
Search
Image
KINIKSA Pharmaceuticals
  • United Kingdom 
    Kiniksa Pharmaceuticals
    International, plc
    Kiniksa Pharmaceuticals (UK), Ltd.
    Second Floor
    105 Piccadilly
    London, UK
    W1J 7NJ
  • USA Headquarters
    Kiniksa Pharmaceuticals Corp.
    100 Hayden Avenue
    Lexington, MA 02421 USA
    (781) 431-9100
  • Switzerland
    Kiniksa Pharmaceuticals, GmbH
    Grafenaustrasse 5
    6300 Zug, Switzerland
  • USA California
    Kiniksa Pharmaceuticals Corp.
    3366 N. Torrey Pines Court
    #320
    La Jolla, CA 92037
Copyright © 2026 Kiniksa Pharmaceuticals
All Rights Reserved. All trademarks mentioned are the property of their respective owners.
Terms of Use | Privacy Policy | Accessibility Statement
|Cookie Policy | Cookie Settings